Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Kansas Organizations Sign Nationwide Petition Regarding Access To Condoms In CVS Stores
The Kansas City Star on Sunday examined a national petition -- signed recently by several local organizations -- requesting that CVS Caremark unlock condoms in all of its CVS pharmacy stores. "The petition, sponsored by the labor coalition Change to Win, said CVS stores tended to lock up condoms, especially in low-income neighborhoods with high numbers of minorities," the Star reports. CVS has said the practice is "a defense against shoplifters in stores where large numbers of condoms were stolen," according to the Star. CVS spokesperson Mike DeAngelis said not all condoms are locked in display cases. "DeAngelis also said the group behind the condom petition ò€¦ was mounting a smear campaign against CVS because of a labor dispute," the article states (Erickson, 7/12).
generic viagra online
Let's Get Moving For Heart Children's Health!
The Children"s Heart Federation (CHF) launches Let"s Get Moving for Heart Children"s Health: a call to action to include children with congenital heart disease in PE at school and to increase their access to sport in the community, at its House of Common"s reception today (14 May) in the presence of Gerry Sutcliffe MP, Minister for Sport and one hundred delegates, including representatives of nine leading sports development organisations. The event, which takes place during Children"s Heart Week (9-17 May), is designed to highlight the right of children and young people with congenital heart disease (CoHD) to sporting opportunities, in order to tackle the exclusion of pupils with CoHD from PE.
News of the day
Shire Has Filed A Treatment Protocol For Velaglucerase Alfa For Gaucher Disease
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher Disease patients, it has filed a treatment protocol for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Gaucher Disease.
Mental Health

Goal Of Good Quality Medicines Advanced By New USP Agreement With 9 ASEAN Countries

Furthering its mission to improve the quality of medicines worldwide, the U.S. Pharmacopeial (USP) Convention has signed a cooperative agreement with nine countries belonging to the Association of Southeast Asian Nations (ASEAN). In a drive to strengthen capacities and certification status of national drug quality control laboratories, officials from Cambodia, Laos, Myanmar, Singapore, Vietnam, Indonesia, Malaysia, the Philippines and Thailand had formed an ASEAN Reference Materials Working Group (ARMWG) to focus on modern, international measurement standards for medicines in the region. The agreement with USP is the culmination of discussions that started in 2008 with the aim of improving the production, precision and quality of ASEAN Reference Substances (ARS). According to Roger L. Williams, M.D., chief executive officer of USP, "This agreement is a milestone in our shared goal of improving the quality of medicines in the region and around the world. We all recognize the importance of long-term strategies to ensure the availability of good quality medicines, and we believe that by working together that goal becomes more readily achievable." At an event to commemorate the signing of the agreement, Mr. Niphon Popattanachai, the deputy director-general of the department of medical sciences at the Thai Ministry of Public Health, said, "We have been working for many years to strengthen the pharmaceutical sector within ASEAN countries, and to become more self-reliant in training scientific staff within our drug quality control laboratories. Our partnership with USP-as well as with the World Health Organization (WHO), the British National Institute for Biological Standards and Control, the Japan Pharmaceutical Manufacturers Association, and others-will offer valuable collaborative res and scientific exchange." Areas of potential collaboration under the agreement include working toward WHO and ISO measurement standards for medicines; promoting ISO certification for ASEAN drug quality control laboratories; support for joint studies and scientist exchange programs; and mutual development of ways to combat counterfeit and substandard medicines. Francine Pierson US Pharmacopeia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009